Results 51 to 60 of about 485,527 (247)

Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis

open access: yesNeurology: Neuroimmunology & Neuroinflammation, 2021
Background and Objectives To determine the real-world use of rituximab in autoimmune encephalitis (AE) and to correlate rituximab treatment with the long-term outcome.
F. Thaler   +21 more
semanticscholar   +1 more source

Autoimmune encephalitis associated with COVID-19: A systematic review

open access: yesMultiple Sclerosis and Related Disorders, 2022
Introduction There are increasing reports of COVID-19 related neurological complications which may be due to direct viral invasion, or immune mediated inflammatory diseases such as autoimmune encephalitis and ADEM (acute demyelinating encephalomyelitis).
F. Nabizadeh   +5 more
semanticscholar   +1 more source

Comparison of commercial and in-house tissue-based and cell-based assays for the detection of autoantibodies targeting neuronal surface proteins: a prospective cohort study

open access: yesFrontiers in Immunology
IntroductionThe detection of antibodies targeting neuronal antigens is a keystone for the diagnosis of autoimmune encephalitis (AE) and paraneoplastic neurological syndromes (PNS).
David Goncalves   +17 more
doaj   +1 more source

NMDA Autoimmune Encephalitis and Severe Persistent Hypokalemia in a Pregnant Woman

open access: yesBrain Sciences, 2022
Introduction: For more than a decade, NMDAR autoimmune encephalitis has been studied and treated as a neurological condition, and good results have been achieve through immune therapies.
Daniela Reisz   +4 more
doaj   +1 more source

Clinical manifestations and immunomodulatory treatment experiences in psychiatric patients with suspected autoimmune encephalitis: a case series of 91 patients from Germany

open access: yesMolecular Psychiatry, 2022
Autoimmune encephalitis (AE) can rarely manifest as a predominantly psychiatric syndrome without overt neurological symptoms. This study’s aim was to characterize psychiatric patients with AE; therefore, anonymized data on patients with suspected AE with
D. Endres   +32 more
semanticscholar   +1 more source

MRI findings in autoimmune encephalitis.

open access: yesRevue neurologique (Paris)
Autoimmune encephalitis encompasses a spectrum of conditions characterized by distinct clinical features and magnetic resonance imaging (MRI) findings.
T. Hartung   +9 more
semanticscholar   +1 more source

The Neutrophil-to-Lymphocyte and Monocyte-to-Lymphocyte Ratios Are Independently Associated With the Severity of Autoimmune Encephalitis

open access: yesFrontiers in Immunology, 2022
Background The neutrophil-to-lymphocyte ratio (NLR) and monocyte-to-lymphocyte ratio (MLR) are biomarkers that may reflect inflammatory status in some immune-related diseases.
Zhiwei Liu   +5 more
semanticscholar   +1 more source

Brain 18F-FDG PET for the diagnosis of autoimmune encephalitis: a systematic review and a meta-analysis

open access: yesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
To consolidate current understanding of detection sensitivity of brain 18F-FDG PET scans in the diagnosis of autoimmune encephalitis and to define specific metabolic imaging patterns for the most frequently occurring autoantibodies.
Manon Bordonné   +6 more
semanticscholar   +1 more source

Antibody Therapies in Autoimmune Encephalitis

open access: yesNeurotherapeutics, 2022
Autoimmune encephalitis (AE) comprises a heterogeneous group of disorders in which the host immune system targets self-antigens expressed in the central nervous system.
I. Smets, M. Titulaer
semanticscholar   +1 more source

Assessment of long-term psychosocial outcomes in N-methyl-D-aspartate receptor encephalitis – the SAPIENCE study protocol

open access: yesBMC Neurology
Background N-methyl-D-aspartate-receptor (NMDAR) encephalitis is a rare neurological autoimmune disease with severe neuropsychiatric symptoms during the acute phase.
Ole Jonas Boeken   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy